UNC Health announced it has filed a state Certificate of Need application for a proposed new hospital in Wilmington. Atrium Health submitted an application to the state for a Certificate of Need to ...

WILMINGTON, N.C. (AP) - An experimental pill is providing new hope for patients with advanced pancreatic cancer, one of the deadliest malignancies that often shows no early symptoms, according to the ...

Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...

A new pill to treat metastatic pancreatic cancer, daraxonrasib, nearly doubles survival time compared to traditional chemotherapy, according to study findings presented at an American Society for ...

As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a ...

A cancer treatment delivered through a simple injection eliminated tumours in some patients and significantly shrank them in others during an international clinical trial involving people with ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options. This novel approach, ...

aDepartment of Oncology, Shanghai East Hospital, Tongji University, Shanghai, China bDepartment of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, ...